At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

The “Make America Healthy Again” movement cheered when Robert F. Kennedy Jr. was confirmed as HHS secretary, but their wish ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

The US Centers for Disease Control and Prevention's outside panel of vaccine experts this week discussed narrowing ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

RSV vaccines could get broader CDC backing for adults aged 50-59 at risk after an endorsement from an agency's expert panel. Read more here.

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...